The Regional Business Manager (RBM) LSD is responsible for accelerating patient diagnosis in the rare metabolic space by building relationships with physicians and accounts. This involves leveraging data analysis and business planning to provide scientific data and in-depth knowledge of Takeda's Lysosomal Storage Disorder products.
The RBM will collaborate with healthcare providers and internal stakeholders to offer educational resources for early diagnosis and treatment, focusing on diseases like Gaucher and Hunters (MPS II) Syndrome.